chrisvoncsefalvay/vaers-outcomes huggingface dataset:
DIZZINESS; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805025,  expiry: UNKNOWN) .5 ml, administered on 10-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 11-MAR-2021, the subject experienced dizziness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from dizziness. This report was non-serious.
Patient was called and told about the new Bivalent booster vaccine and will call and get that when she has time.
Approximately, 11 hours after the shot Severe cold chills, so severe my teeth would not stop chattering. I was shaking so hard my body ached from shaking. Goosebumps, a crazy headache.  I thought i was having an anurysm.  Not a normal headache.  Cold sweats so bad you could just about wring out my sheets and clothes. Nausea, some vomiting.  On a scale of 1-10 of these symptoms is was an 11-12.  These symptoms changed as the days went on.  In the moring of the first night.  I was ok.  Woke up with a bad headache, still nauseas and still cold but not like at night tollerable.  About 5PM day 2 it started all over again, just as severe.  Next moring ok.  This pattern kept reapeating for 4 days.  Food now getting repulsive.  No way I  could eat anything.  On day 5 the symptoms continue now throug the day, however the teeth chattering not happeing and the cold chills a bit less severe.  I would say by day 5 on the scale of 1-10 i am now about a 9. This was so horrible for so long.  Every single night i would wake up soaked in my own sweat.  This is still happening 11 days later.  I am still experiencing headaches.  I never have headaches.  I did not go to a Doctor because i figured what are they going to do, i have to ride this out.  Also a strange thing is took my temparture daily and seveal times.  Zero temprature. by day 5 I could not get out of bed for 3 days.  Day 8 things getting better, still cold chills and headaches but not as bad.  Day 9 way better, now getting hungry. Daytime cold chills now gone mostly less headaches.  Oddly headaches and cold chills start about 4-5pm and continue through the night.  In the morning i wake up with a headache still today.
Headache; Arm pain; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) and PAIN IN EXTREMITY (Arm pain) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-May-2021, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-May-2021, the patient experienced HEADACHE (Headache) and PAIN IN EXTREMITY (Arm pain). At the time of the report, HEADACHE (Headache) and PAIN IN EXTREMITY (Arm pain) outcome was unknown.            Concomitant medications were not reported.  No treatment details were provided.
Days 1-3: sore arm Days 8-10: itchiness, red circular rash around injection site, swelling
injection site / painful; injection site / itchy; injection site / swollen lump; injection site was hot; injection site / red; injection site / lump; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 75-year-old female patient who received DTPa (DTaP vaccine) (batch number C5630AA ?, expiry date 21st November 2021; GSK Note: batch number did not match with sales data sheet) for prophylaxis.   On 23rd October 2020, the patient received DTaP vaccine. On 25th October 2020, 2 days after receiving DTaP vaccine, the patient experienced injection site pain, injection site itching, injection site swelling, injection site warmth, injection site erythema and injection site lump. On an unknown date, the outcome of the injection site pain, injection site itching, injection site swelling, injection site warmth, injection site erythema and injection site lump were unknown.   It was unknown if the reporter considered the injection site pain, injection site itching, injection site swelling, injection site warmth, injection site erythema and injection site lump to be related to DTaP vaccine.  Additional details were provided as follows: The patient received DTaP vaccine from by 25th October 2020 the patient noticed the injection site was hot, swollen lump, red, itchy, and painful.  The patient does not know the brand name of the vaccine.  The reporter consent to follow up.
2/12/21-48 hours after first Moderna  vaccine adverse event occur. He has a history of MI and Agent Orange exposure. He awoke from his sleep with palpitations and chest pain.  He said he maybe  breathing was affected. He arose from his bed, sat in a chair, and sipped warm water with easing of discomfort. Although he had a NTG, he did not choose to take any, nor did he check his pulse.  Not wishing to repeat the experience, he refused a second vaccination.
no adverse event; administered Moderna Covid-19 vaccine to a patient who was administered with Pfizer as 1st dose; administered Moderna Covid-19 vaccine to a patient who was administered with Pfizer as 1st dose; This spontaneous case was reported by a nurse and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (administered Moderna Covid-19 vaccine to a patient who was administered with Pfizer as 1st dose), COVID-19 IMMUNISATION (administered Moderna Covid-19 vaccine to a patient who was administered with Pfizer as 1st dose) and NO ADVERSE EVENT (no adverse event) in a 3-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. FT9142) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: Pfizer (Dose 1 (0.2ml). Lot number: FT9142) on 07-Jul-2022. Past adverse reactions to the above products included No adverse event with Pfizer.    On 01-Sep-2022, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 01-Sep-2022, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (administered Moderna Covid-19 vaccine to a patient who was administered with Pfizer as 1st dose) and COVID-19 IMMUNISATION (administered Moderna Covid-19 vaccine to a patient who was administered with Pfizer as 1st dose). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (administered Moderna Covid-19 vaccine to a patient who was administered with Pfizer as 1st dose), COVID-19 IMMUNISATION (administered Moderna Covid-19 vaccine to a patient who was administered with Pfizer as 1st dose) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessments were provided for INTERCHANGE OF VACCINE PRODUCTS (administered Moderna Covid-19 vaccine to a patient who was administered with Pfizer as 1st dose) and COVID-19 IMMUNISATION (administered Moderna Covid-19 vaccine to a patient who was administered with Pfizer as 1st dose).    No concomitant drug information was provided.  It was reported that patient was inadvertently administered Moderna COVID-19 vaccine by the nurse who was administered with Pfizer as first dose. No adverse events were reported at the time of the call.  No treatment drug information was provided.
a nurse accidentally gave a dose of Fluzone HD to a 17 year old patient, no AE; a nurse accidentally gave a dose of Fluzone HD Quadrivalent to a 17 year old patient, no AE; Initial information was received on 15-Sep-2020 regarding an unsolicited valid non-serious case from a consumer or non-health care professional.  This case involves a 17-year-old female patient who was vaccinated with a 0.7 ml dose of INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT] (lot UJ468AB and expiration date 30-Jun-2021) via an intramuscular route in the left deltoid on 14-Sep-2020 for prophylactic vaccination.  The patient's medical history, past medical treatment(s), vaccination(s) and family history were not provided.  The patient had concomitantly vaccinated with a dose of MENINGOCOCCAL VACCINE A/C/Y/W CONJ (DIP TOX) (MENACTRA) on 14-Sep-2020 for prophylactic vaccination.  It was an actual medication error case due to inappropriate age at vaccine administration and overdose (latency was same day).  At the time of reporting, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Nausea, headache, paresthesia fingertips and toes, lightheaded, and crampy, chills, achy (B) testicle, loose stool/diarrhea x3.
a patient was administered an improperly stored PROQUAD; no additional adverse events; This spontaneous report was received from a medical assistance referring to a patient of unknown age and gender.   The patient's concurrent conditions, medical history and concomitant medications were not reported.   On 17-DEC-2019, dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), lot # S022913 and expiration date 19-JAN-2021 (dose, route and frequency were not reported) as prophylaxis, which was improperly stored in a temperature of 36.86 °F in a timeframe of 9 hours and 49 minutes and reconstituted with a properly stored sterile diluent (STERILE DILUENT MRK INJ) was administered to the patient.   It was reported that previous temperature excursion occurred with a temperature of 15 °F within 1 hour and 30 minutes.   No adverse symptoms were reported for the patient.
pt recv vax;was fine at first then lean head against wall, went limp;LOC momentarily;jerking body movements;given inhaled ammonia,elev feet;felt n;better but had chills & fever & lt arm sore when arrived home;to bed;pt back to work today;
Fever of 102, feeling very tired.  Fever continues next day of 101, symptoms ongoing as of time of this report. Weekend so can not speak to clinic.
630PM numbness-tingling of extremities; t101, loss of consciousness; BP 142/98, R26, P82; blood shot eyes; no wheezing or rash; observed w/02 x 30 mins released instructed to inc fluid; APAP for temp;
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. On or about 16-NOV-2015 the patient was inoculated with the ZOSTAVAX vaccine at a doctor's office as recommended for routine adult health maintenance for the prevention of shingles (dose, route, and lot # not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain of herpes zoster or shingles. On or about 15-SEP-2016, the patient was treated by a physician at a hospital for a severe vesicular outbreak, which was diagnosed as herpes zoster. The patient was prescribed lidocaine, oxycodone, valacyclovir hydrochloride (VALTREX) and acyclovir for management of his painful symptoms and excrutiating pain. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Additional information has been requested.
Initial information received from a consumer on 18 November 2013. A 20-year-old female patient whose medical history was not reported had received a flu shot (manufacturer unknown) (batch number, route and site of administration not reported) on 15 November 2013. On an unspecified date, the patient had lot of pain at the injection site but also traveled through her shoulder blade. The patient was ok very next day. Lab investigations and treatment medications were not reported. List of documents held by sender: none  Follow-up information received from a health care professional on 17 January 2014: No additional information was available.
elevated heart rate during exercise, 20 beats over normal, returned to normal 2 days later
Swollen upper arm, tender, red and warm to touch, feeling of tightness pt states she had same rxn to previous vaccination years ago.
Generalized weakness, tremors, paresthesia, ataxia, involuntary movement, back and head pain, urinary incontinence, hypersensitive, sensory problems, incoordination. Preliminary diagnostic (Guillain Barre), second (encephalomyelitis), finally myelopathy. The treatment included hospitalization and rehabilitation program.
pt has a scar on rt leg 918mm length) approx mid thigh;there is an indentation in tissue beneath the scar which can be felt;MD states to mom this is a rxn to vax; 16DEC96;
sweats; I woke to extreme nausea; low grade fever; malaise; Initial information received on 12-Sep-2022 regarding an unsolicited valid  non-serious case received from a consumer/non-health care professional  This case involves a 57 years old female patient who experienced sweats,  woke to extreme nausea, low grade fever and malaise after receiving vaccine INFLUENZA USP TRIVAL A-B SUBVIRION NO PRESERVATIVE VACCINE [FLUZONE].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   In 2007 followed by dose o 11-Sep-2022, the patient received a  dose of suspect INFLUENZA USP TRIVAL A-B SUBVIRION NO PRESERVATIVE VACCINE lot number not reported at an unknown dose via intramuscular route in unknown administration site as flu vaccination.  It was reported  that the patient have received a flu vaccination for the past 15 years. Early morning of Sept 12, the patient  woke to extreme nausea, low grade fever (pyrexia), sweats (hyperhidrosis)and malaise.(latency: 1 day for dose on 11-Sep-2022) . The rest of the day, of Sept 12, the patient could barely stay awake and had to lay on the couch for support. The symptoms finally lessened at approximately 2pm on Sept 12, that the patient  could perform some of my daily activities. By the morning of Sept 13, there were no lingering symptoms.  Action taken :not applicable.  It was not reported if the patient received a corrective treatment for the events.   Outcome: recovered for all events
Small sores in throat, 6-10 hours/day fever/flu-like symptoms requiring 1-2 additional Hydrocodone/APAP per day, headache, muscle/joint pain, stomach pain, pain in legs and gluteus when sitting, inability to stand.
Vomiting after vaccine. Felt headache and then vomiting after vaccine. There was slight dehydration before taking vaccine.
blood in urine...this occured when i was a child 3 times but we were unable to identify the cause.
1030AM flu shot given lt clinic; returned 1130AM stated hands itching & throat feels like itching & swelling-refused DPH shot;
have experienced a side effect; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (have experienced a side effect) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (have experienced a side effect). At the time of the report, VACCINATION COMPLICATION (have experienced a side effect) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medication information was reported. No treatment medications were provided.
pt states that her right arm got red around the injection site and had a spot in the center that looked like a blister.  She then noticed she had another spot that turned red in the bend of her right arm that formed into a blister.   Both of these spots got infected and formed puss.  She had to clean them, put Neosporin on them  and then cover them.  When she took the bandages off she would have to drain them.  They have knots under the skin.  She has 2 blisters on her left side of the her belly that are infected and painful.  They drain and have knots under the skin. She also has some very red blisters on her upper stomach but they did not get infected.  She is cleaning all of them with wound cleaner.  Pt has an appt w/her PCP on 3/17/2021.
Patient received Pneumovax on the right arm without incident.   She was then given the HPV vaccine on the left arm.  This time she had pain and proceeded to faint.  This was her third HPV vaccine.  Apparently, she fainted with the first HPV vaccine.  The second was given while she was lying down and only experienced pain at the site of injection.
Patient complained of dizziness and feeling clammy. Patient was given an ice pack. Patient was not able to answer question (What day is it?) and Mom requested that paramedics be called. While waiting for the paramedics patient continued to complain of dizziness, feeling clammy/cold and changes in vison (zig zag lines).Just prior to paramedics arriving Patient was able to sit up on her own, answer questions (What day is it and Who is the President?), but still complaining of feeling cold and vision problems, Paramedics arrived and took Patient to the Ambulance to further evaluate her.
I had the expected symptoms of chills and low grade fever. The unexpected symptoms were really acidic stomach and I passed out.
Twitching face; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old male patient received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, lot number: EN6199) via an unspecified route of administration in shoulder on 13Mar2021, (at the age of 60-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient was not had any allergies to medications, food and other products. Concomitant medications were not reported. Prior to vaccination, the patient did not diagnose with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 14Mar2021, the patient experienced twitching on left side of the face. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the reported events. The clinical outcome of the event twitching face was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
erythematous, raised eruptions scattered across trunk, back, extremities of variable size w/area of inject showing greatest involvement;
I have missed my second moderna shot, how late is too late to get the shot; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (I have missed my second moderna shot, how late is too late to get the shot) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (I have missed my second moderna shot, how late is too late to get the shot). At the time of the report, PRODUCT DOSE OMISSION ISSUE (I have missed my second moderna shot, how late is too late to get the shot) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided by the reporter   Reporter did not allow further contact
I always had an allergy to tree nuts.  After the booster I developed new allergies and the current ones got worse.  My left eye began to swell up multiple times.  Anytime I had aspirin or advil cold and sinus.  My lips swelled up 2 times.  When I had coconut products my body began to hive up.  I've had the tree nut allergy but never developed hives.   I am 43 years old and have used Aspirin and Advil cold and sinus for 20 years at least.  After the vaccine I've developed an allergy to these medicines.  My eye completely shuts down, eye lids swell up, only on my left eye.
Swollen right arm, no fever, mild pain (redness to right deltoid area, non tender, warm to touch ) treatment: Keflex 250/5 three times a day for 5 days.  (DTAP/AVENTIS/C1526AA).
4 inch diameter red area, warm to the touch, sore (no itching) - ongoing as of date of report.
Nausea within hours of 2nd shot.  Next day extreme body aches/ joint pain, nausea.  Day 2 and 3 tired.  Day 4: extreme headache/migraine, nausea, vomiting, diarrhea, exhaustion.  Day 5: extreme headache, nausea, exhaustion.  Day 6-11: headache and exhaustion.
inadvertent administration after above excursion; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a 32-year-old female patient who received HBV (Engerix B) (batch number D23D3, expiry date 15-MAR-2025) for prophylaxis.   On 17-MAY-2023, the patient received Engerix B. On an unknown date, an unknown time after receiving Engerix B, the patient experienced incorrect storage of drug (Verbatim: inadvertent administration after above excursion). The outcome of the incorrect storage of drug was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 31-May-2023 No reactions were reported. The reporter consented to follow-up via email. The patient received a dose of Engerix-B after being exposed to 73 Fahrenheit to possibly over 168 hours, which led to incorrect storage of drug
Patient received Covid-19 vaccination on 8/25/21.  A few moments after administration of vaccine, patient complained of dizziness, numbness down her arm, tingling of fingers, headache, and back ache.  The local EMS squad was called, and they responded within minutes.  Patient was still conscious, and was taken to nearest hospital to be examined.
The next evening following the vaccine, my right eye swelled (the white of the eye) and my cheek and above my eyebrow became inflamed on the right side only. I visited the ER the next morning and they told me it looked like an unrelated allergic reaction. She said it looked almost like the pattern of shingles but said that was unlikely. Visited another dr who said it looked like the possible beginnings of shingles based on the affected areas and that I should monitor. Face feels hot, eye swelling went away after Benadryl use the first night but cheek and eyebrow are still inflamed.